US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

110.50

-0.0338-0.03%

Post-market: 110.500.00000.00%19:30 EDT

Volume:108.64K

Turnover:12.04M

Market Cap:1.00B

PE:89.54

High:111.36

Open:110.76

Low:110.19

Close:110.53

52wk High:118.00

52wk Low:85.91

Shares:9.09M

Float Shares:9.09M

Volume Ratio:0.54

T/O Rate:1.20%

Dividend:2.18

Dividend Rate:1.97%

EPS(TTM):1.23

EPS(LYR):0.7765

ROE:--

ROA:--

PB:--

PE(LYR):142.31

Loading ...

Overview Company News Filings

Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market

Citi says Novartis news increases likelihood Crispr prioritizes next-gen CTX321

Citi sees limited immediate downside for Ionis after pelacarsen failure

Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial

BofA sees low single-digit percentage downside for Novartis on pelacarsen miss

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial

Novartis India to Acquire 'Minipress' Trademarks from Pfizer

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

Novartis Heart-Trial Failure Could be Mitigated by Investor Caution

Novartis India - Deal Valued at 12.50 Bln Rupees

THOMSON REUTERS

Novartis Shares to Take Hit from Cholesterol Trial Failure

Dow Jones Top Company Headlines at 9 PM ET: Amazon Cargo Plane Overshoots Runway in Miami, Killing Five People | Carmakers ...

Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation

A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal

Stocks to Watch: Ionis Pharmaceuticals, Novartis, Corvex

Novartis Pelacarsen Fails Phase III Cardiovascular Outcomes Trial

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/PPH/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","market":"US","secType":"STK","nameCN":"VanEck Pharmaceutical ETF","latestPrice":110.5,"timestamp":1789588800000,"preClose":110.5338,"halted":0,"volume":108644,"hourTrading":{"tag":"盘后","latestPrice":110.5,"preClose":110.5,"latestTime":"19:30 EDT","volume":55,"amount":6084.72,"timestamp":1789601405786,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0003057888175381592,"floatShares":9088138,"shares":9088138,"eps":1.234146,"marketStatus":"Not Yet Opened","change":-0.0338,"latestTime":"09-16 16:00:00 EDT","open":110.76,"high":111.36,"low":110.19,"amount":12036387.37204,"amplitude":0.010585,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.234146,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":110.5338,"sharesOutstanding":11938138,"nav":110.59843,"aum":994073948.99,"dividendRate":0.01971,"bidAskSpread":0.000395,"preHourTrading":{"tag":"盘前","latestPrice":109.7,"preClose":110.5338,"latestTime":"08:17 EDT","volume":1,"amount":109.7,"timestamp":1789561063190,"change":-0.8338,"changeRate":-0.007543,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":110.5,"preClose":110.5,"latestTime":"19:30 EDT","volume":55,"amount":6084.72,"timestamp":1789601405786,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.540328,"impliedVol":0.2308,"impliedVolPercentile":0.844},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","floatShares":9088138,"roa":"--","roe":"--","lyrEps":0.776475,"volumeRatio":0.540328,"shares":9088138,"dividePrice":2.1779,"high":111.36,"amplitude":0.010585,"preClose":110.5338,"low":110.19,"week52Low":85.9086,"pbRate":"--","week52High":118,"institutionHeld":0,"latestPrice":110.5,"eps":1.234146,"divideRate":0.01971,"volume":108644,"delay":0,"ttmEps":1.234146,"open":110.76,"prevYearClose":103.17,"prevWeekClose":109.44,"prevMonthClose":113.08,"prevQuarterClose":109.35,"fiveDayClose":110.12,"twentyDayClose":113.2,"sixtyDayClose":103.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPH\",params:#limit:5,,,undefined,":[{"date":"2026-07-01","symbol":"PPH","amount":0.6248,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-07"},{"date":"2026-04-01","symbol":"PPH","amount":0.8441,"announcedDate":"2026-03-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-01","defaultRemindTime":1775050200000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-07","payableDate":"2026-04-01","currency":"USD","dateTimestamp":1775016000000,"payDate":"2026-04-07"},{"date":"2025-12-29","symbol":"PPH","amount":0.3106,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-29","defaultRemindTime":1767018600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-29","currency":"USD","dateTimestamp":1766984400000,"payDate":"2025-12-31"},{"date":"2025-10-01","symbol":"PPH","amount":0.3931,"announcedDate":"2025-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-01","defaultRemindTime":1759325400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-06","payableDate":"2025-10-01","currency":"USD","dateTimestamp":1759291200000,"payDate":"2025-10-06"},{"date":"2025-07-01","symbol":"PPH","amount":0.6069,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-01","defaultRemindTime":1751376600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-07-01","currency":"USD","dateTimestamp":1751342400000,"payDate":"2025-07-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-03","recordDate":"2016-10-05","paymentDate":"2016-10-07","value":0.2148,"currency":"USD"},{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.1449,"currency":"USD"},{"executeDate":"2017-04-03","recordDate":"2017-04-05","paymentDate":"2017-04-07","value":0.4651,"currency":"USD"},{"executeDate":"2017-07-03","recordDate":"2017-07-06","paymentDate":"2017-07-10","value":0.304,"currency":"USD"},{"executeDate":"2017-10-02","recordDate":"2017-10-03","paymentDate":"2017-10-06","value":0.221,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPH\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665731749","title":"Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665731749?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:02","pubTimestamp":1788796920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B were flat  at DKK298.95 Monday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.3% to 2,710.84.The stock's rise  snapped a two-day losing streak.The company closed DKK111.00 short of its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 1,797,150, compared to the 50-day average trading volume of 4,122,224.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","THNR","OZEM","IE00BKVL7J92.USD","BK4585","NVO","NVOH","LU1093756168.USD","LU0154236417.USD","BK4588","NVOC","LU1093756325.SGD","BK4599","BK4007","BK4532","IE00BZ1G4Q59.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665176793","title":"Citi says Novartis news increases likelihood Crispr prioritizes next-gen CTX321","url":"https://stock-news.laohu8.com/highlight/detail?id=2665176793","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665176793?lang=en_us&edition=fundamental","pubTime":"2026-09-07 23:20","pubTimestamp":1788794419,"startTime":"0","endTime":"0","summary":"After Novartis (NVS) reported that pelacarsen’s Phase 3 HORIZON study failed to demonstrate a statistically significant reduction in major adverse ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-says-novartis-news-increases-likelihood-crispr-prioritizes-next-gen-ctx321-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-says-novartis-news-increases-likelihood-crispr-prioritizes-next-gen-ctx321-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","LU0320765489.SGD","IE00BJJMRZ35.SGD","NVS","BK4007","IE00B4R5TH58.HKD","BK4585","IE00BFTCPJ56.SGD","BK4588","IE0002141913.USD","LU0208291251.USD","BK4578","LU0211331839.USD","PPH","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0070302665.USD","BK4532","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665552317","title":"Citi sees limited immediate downside for Ionis after pelacarsen failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2665552317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665552317?lang=en_us&edition=fundamental","pubTime":"2026-09-07 23:15","pubTimestamp":1788794109,"startTime":"0","endTime":"0","summary":"After Ionis’ (IONS) partner Novartis (NVS) disclosed that the pelacarsen Phase 3 Lp(a)HORIZON study failed to meet its primary endpoint of cardiova...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-sees-limited-immediate-downside-for-ionis-after-pelacarsen-failure-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-sees-limited-immediate-downside-for-ionis-after-pelacarsen-failure-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4578","BK4588","IE00BJJMRZ35.SGD","BK4007","IE00B4R5TH58.HKD","LU0070302665.USD","PPH","BK4585","BK4532","MEDX","LU0211331839.USD","IE00BFTCPJ56.SGD","LU0208291251.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE0002141913.USD","NVS","IE0009355771.USD","LU0320765489.SGD","BK4139","IONS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131175","title":"Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131175?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:32","pubTimestamp":1788784376,"startTime":"0","endTime":"0","summary":"Novo Nordisk’s ($NVO) shares in Copenhagen edged lower on Monday afternoon. This came even after the Danish pharma giant said in a statement that i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVO","LU0154236417.USD","LU1093756168.USD","BK4599","BK4532","BK4588","IE00BKVL7J92.USD","LU1093756325.SGD","THNR","NVOX","NVOH","NVOC","BK4007","OZEM","IE00BZ1G4Q59.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311682","title":"BofA sees low single-digit percentage downside for Novartis on pelacarsen miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311682","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311682?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:00","pubTimestamp":1788782433,"startTime":"0","endTime":"0","summary":"After Novartis (NVS) announced pelacarsen missed its primary endpoint of reducing cardiovascular events in the Phase 3 HORIZON study, BofA sees low...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bofa-sees-low-single-digit-percentage-downside-for-novartis-on-pelacarsen-miss-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bofa-sees-low-single-digit-percentage-downside-for-novartis-on-pelacarsen-miss-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","IE0009355771.USD","LU0208291251.USD","IE00BJT1NW94.SGD","PPH","BK4578","IE00BFTCPJ56.SGD","BK4585","LU0070302665.USD","BK4588","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0211331839.USD","MEDX","BK4532","NVS","LU0320765489.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665023390","title":"ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2665023390","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665023390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:35","pubTimestamp":1788770131,"startTime":"0","endTime":"0","summary":"ASB Ventures-backed Boundary Zhikong’s Navista eVTOL navigation system enters CAAC airworthiness reviewShenzhen ASB Ventures portfolio company Boundary Intelligent Control secured CAAC acceptance of a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL7rkwzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770308.USD","LU2360106947.USD","LU1035775433.USD","LU1868837136.USD","LU0210536198.USD","LU2237443465.HKD","LU0345770993.USD","IE00BJLML261.HKD","LU0943347566.SGD","LU2237443978.SGD","LU2552382132.HKD","IYH","SG9999015952.SGD","GDOC","LU0158827948.USD","SG9999015986.USD","LU1093756325.SGD","IE00BFSS7M15.SGD","ASB","LU0640476718.USD","LU0820561818.USD","LU0889565916.HKD","LU2361044949.HKD","LU1093756168.USD","LU2063271972.USD","LLYZ","LU0466842654.USD","LU1720051108.HKD","LU2237443622.USD","IE0004445239.USD","SGXZ51526630.SGD","LU2112291526.USD","LU0106261372.USD","LU0203202063.USD","BK4585","LU2471134879.HKD","LU0385154629.USD","LU1983299246.USD","IE00BJJMRY28.SGD","LU0079474960.USD","LU0320765059.SGD","LU2462591350.SGD","LU0058720904.USD","SG9999015945.SGD","LU1720051017.SGD","SG9999001176.SGD","LU1623119135.USD","LU0096364046.USD","LU2023250330.USD","BK4533","LU0109394709.USD","BK4581","LU1069344957.HKD","JDOC","LU1917777945.USD","LU2491050071.SGD","LU2168564149.EUR","IE00B775H168.HKD","HRTS","LU1280957306.USD","LU1548497426.USD","LU1988902786.USD","LU1691799644.USD","LU1989771016.USD","LU2087625088.SGD","LU2237443549.SGD","LU2237438978.USD","LU2089283258.USD","LU2357305700.SGD","LU0006306889.USD","SG9999015978.USD","LU2491050154.USD","LU0417517546.SGD","LU0353189763.USD","LU0432979614.USD","LU2237443895.HKD","IE00BN29S564.USD","LU2211815571.USD","IXJ","LU0198837287.USD","LU0683600562.USD","IE00BJT1NW94.SGD","LU2168564222.USD","LU2756315664.SGD","LU0353189680.USD","LLYX","LU2462157665.USD","LU0203201768.USD","LU0882574139.USD","LU2168564495.EUR","LU1291159041.SGD","LU1868836914.USD","LU2361044865.SGD","ILDR","LU0787776722.HKD","LU0320765992.SGD","LU0316494557.USD","LU1629891620.HKD","LU1323610961.USD","LU2106854487.HKD","LU0471298777.SGD","LU0158827781.USD","LU0456855351.SGD","IE0001KFT4U8.USD","LU1868836757.USD","IE00BKDWB100.SGD","TMED","LU0672654240.SGD","LU2756315318.SGD","LU2552382215.SGD","LU0097036916.USD","LU0471298694.HKD","LU2552382058.USD","MEDX","TRUH","LU0323591593.USD","LU0882574055.USD","LU0238689110.USD","LU1145028129.USD","XLV","MEDI","SGXZ99366536.SGD","SG9999014914.USD","LU1127390331.HKD","BK4211","LU1551013342.USD","LU2750360641.GBP","LU2746668974.SGD","LU2750360997.AUD","LU2461242641.AUD","WDNA","LU1061106388.HKD","IE0004445015.USD","LU0061475181.USD","LU0133085943.USD","LU0689472784.USD","LU0820562030.AUD","LU2028103732.USD","LU1804176565.USD","LU0094547139.USD","LU2168563687.JPY","IE00BFTCPJ56.SGD","LLII","LU1979441026.SGD","LU0708995401.HKD","LU1868836591.USD","LU1267930730.SGD","LU2023250504.SGD","BK4516","IE00BWXC8680.SGD","LU2361045086.USD","IE00BK4W5L77.USD","LU0256863902.USD","LU0289739699.SGD","LU2089284900.SGD","SG9999001176.USD","LU2023251221.USD","IE0002141913.USD","LU0964807845.USD","LU2111349929.HKD","FTXH","LU1712237335.SGD","IE00B4R5TH58.HKD","LU0354030511.USD","LU2265009873.SGD","VHT","LU2602419157.SGD","LU0786609619.USD","IE00BJJMRZ35.SGD","OZEM","IE00BK4W5M84.HKD","GB00BDT5M118.USD","LU2417539215.USD","SG9999014898.SGD","LU2471134796.USD","LU1232071149.USD","LU2471134952.CNY","LU2896262040.SGD","LU0109391861.USD","SG9999018857.SGD","MHIP","LU2324357040.USD","SG9999017495.SGD","LU1551013425.SGD","SG9999014906.USD","ELIS","IE0009355771.USD","LU0823434583.USD","SGXZ57979304.SGD","LU1814569148.SGD","LU2264538146.SGD","RXL","LU1057294990.SGD","AGNG","IE00B2B36J28.USD","BK4007","LU0823416689.USD","IE00B1XK9C88.USD","LU2491049909.HKD","SG9999014880.SGD","LU2456880835.USD","LU0225283273.USD","LU0256863811.USD","LU0823434740.USD","IE00B1BXHZ80.USD","LU2089984988.USD","IE00B4JS1V06.HKD","LU1868837300.USD","PPH","CURE","LU2108987350.USD","IHE","LU0266013472.USD","LU1974910355.USD","LU2236285917.USD","LU2468319806.SGD","LU1023059063.AUD","LU2271345857.HKD","SG9999018865.SGD","SGXZ31699556.SGD","PJP","LU0354030438.USD","LU1064131342.USD","CANC","LU0174119429.USD","LU2237443382.USD","IE00BJJMRX11.SGD","SG9999013999.USD","LU0234572021.USD","LU2168564065.EUR","IE0005OL40V9.USD","BK4599","LU0820561909.HKD","LU2471134523.USD","LU2213496289.HKD","BK4588","LU2746668461.USD","THNR","FHLC","IE00BKPKM429.USD","LU0122379950.USD","IE00BFSS8Q28.SGD","BK4534","LLY","LU0114720955.EUR","IE00B7KXQ091.USD","SGXZ81514606.USD","LU1366192091.USD","ELIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390614","title":"Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390614","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390614?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768672,"startTime":"0","endTime":"0","summary":"UPDATE 2-Novartis cholesterol setback tests hopes for emerging heart disease drugsLONDON, Sept 7 (Reuters)-Shares of NovartisNOVN.Sfell more than 3% on Monday after its cholesterol drug failed in a cl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL1N44Z05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLYZ","VHT","AMGN","XLV","TMED","LLII","IXJ","LLY","IE00BJJMRY28.SGD","OZEM","THNR","PBE","FTXH","BBH","CANC","GDOC","AGNG","SGXZ99366536.SGD","HRTS","CURE","ELIS","JDOC","IBB","LU1691799644.USD","LU2750360641.GBP","IHE","TRUH","ELIL","RXL","PJP","IBBQ","LU1571399168.USD","LU0097036916.USD","LU0823434583.USD","WDNA","LU2089284900.SGD","MEDX","SLN","TBXU","IYH","MEDI","MHIP","LU2361044865.SGD","FHLC","LLYX","BIB","PPH","NAMS","LU1267930730.SGD","ILDR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665572390","title":"Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665572390","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665572390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:03","pubTimestamp":1788768180,"startTime":"0","endTime":"0","summary":"Novartis shares fell after the Swiss drugmaker said an experimental medicine failed to reduce cardiovascular risk in a late-stage clinical trial.Shares in Novartis were down 3.2% in European morning t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","LU0208291251.USD","IE00B2B36J28.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","NVS","BK4532","PPH","IE0002141913.USD","IE00B4R5TH58.HKD","MEDX","BK4007","BK4588","LU0070302665.USD","LU0211331839.USD","BK4585","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397422","title":"Novartis India to Acquire 'Minipress' Trademarks from Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397422","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397422?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:43","pubTimestamp":1788767020,"startTime":"0","endTime":"0","summary":"BRIEF-Novartis India To Acquire 'Minipress' Trademarks From PfizerSept 7 (Reuters)-Novartis India LtdNOIN.BO:TO ACQUIRE 'MINIPRESS' TRADEMARKS FROM PFIZERSource text:ID:nBSE74jJ9yFurther company coverage:NOIN.BO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44Y00E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0058720904.USD","SG9999003800.SGD","BK4581","LU0321505439.SGD","LU1057294990.SGD","PPH","LU1066053197.SGD","LU0868494617.USD","LU1023059063.AUD","IE00BBT3K403.USD","LU1066051498.USD","IE00BLSP4239.USD","LU0122379950.USD","BK4592","LU0208291251.USD","LU0456855351.SGD","SG9999011175.SGD","SG9999002232.USD","LU0234572021.USD","IE0002270589.USD","LU0211331839.USD","LU0306806265.USD","BK4585","LU0306807586.USD","PFE","LU0320765489.SGD","LU0289739699.SGD","BK4533","SG9999002224.SGD","IE00BJJMRZ35.SGD","LU0985481810.HKD","BK4007","LU1894683264.USD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU1883839398.USD","BK4599","IE0009355771.USD","IE000M9KFDE8.USD","LU0170899867.USD","LU0225284248.USD","LU0225771236.USD","OZEM","SGXZ57979304.SGD","IE00B19Z3B42.SGD","BK4550","NVS","BK4534","LU0321505868.SGD","LU1894683348.USD","IE0002141913.USD","MEDX","SG9999013999.USD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","BK4532","SG9999001176.SGD","BK4588","IE00B4R5TH58.HKD","BK4568","BK4578","IE00B3T34201.USD","SG9999001176.USD","LU0070302665.USD","LU2596442595.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104786890","title":"Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1104786890","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104786890?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:22","pubTimestamp":1788765738,"startTime":"0","endTime":"0","summary":"Swiss pharma giant Novartis AG (NVS.US) has suffered another clinical trial setback, marking the second high-profile candidate to fail in late-stage studies within a single week. The latest casualty...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU0868494617.USD","LU1023059063.AUD","LU1057294990.SGD","LU2112291526.USD","IBBQ","LU0208291251.USD","LU0122379950.USD","LU1571399168.USD","LU0889565916.HKD","BK4532","AMGN","PJP","BK4533","BK4599","IE0009355771.USD","SG9999001440.SGD","LU0320765489.SGD","LU0289739699.SGD","LU2242652126.USD","BK4566","IBB","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4534","LU0211331839.USD","LU2089984988.USD","BIB","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4578","BK4139","LU0109394709.USD","LU0320765992.SGD","NVS","BK4585","PBE","LU0058720904.USD","LU2468319806.SGD","LU1061106388.HKD","BK4588","IE00BJJMRZ35.SGD","BK4007","LU0070302665.USD","PPH","IE0002141913.USD","MEDX","LU1983299246.USD","BBH","LU2242646821.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392965","title":"Novartis Heart-Trial Failure Could be Mitigated by Investor Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392965","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392965?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:04","pubTimestamp":1788764640,"startTime":"0","endTime":"0","summary":"0703 GMT - An experimental Novartis medicine missed the target in a late-stage clinical trial, but the hit to the Swiss drugmaker's share price could be mitigated by investors' skepticism about the study, analysts at Citi say in a research note. The drug, pelacarsen, reduced the levels of a fatty particle in the blood known as Lp, but this didn't translate to clinical outcomes, Citi says. \"We think market expectations of a positive trial were already cautious, with question marks around the magnitude of benefit and difficulty in commercialization even if the study had met the endpoint, which we think could limit the impact of the trial failure on the share price,\" the analysts say.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS","BK4588","BK4007","PPH","LU0211331839.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","MEDX","IE0002141913.USD","BK4578","BK4532","LU0070302665.USD","BK4585","LU0208291251.USD","LU0320765489.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665391143","title":"Novartis India - Deal Valued at 12.50 Bln Rupees","url":"https://stock-news.laohu8.com/highlight/detail?id=2665391143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665391143?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:56","pubTimestamp":1788760577,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44Y00E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0211331839.USD","BK4585","BK4532","IE00BJT1NW94.SGD","NVS","BK4578","LU0070302665.USD","MEDX","IE00B2B36J28.USD","IE0002141913.USD","BK4007","IE00BJJMRZ35.SGD","BK4588","PPH","IE00B4R5TH58.HKD","LU0208291251.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665684391","title":"Novartis Shares to Take Hit from Cholesterol Trial Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2665684391","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665684391?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:43","pubTimestamp":1788759780,"startTime":"0","endTime":"0","summary":"0543 GMT - Novartis shares are likely to take a hit from news that a cholesterol drug candidate failed to reduce the risk of severe cardiovascular events like heart attacks and strokes in a late-stage trial, J.P. Morgan analysts say in a research note. Consensus estimates for Novartis included $1 billion in 2030 sales from the drug, called pelacarsen, the analysts say. Shares in the Swiss drugmaker are likely to be off 2% to 3% on Monday as a result, they add. Upcoming trial results for del-desiran, an experimental treatment for genetic neuromuscular disorder myotonic dystrophy type 1, are likely to be positive and could allow Novartis to more than erase stock weakness caused by the pelacarsen results, according to JPM.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Novartis Shares to Take Hit from Cholesterol Trial Failure","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211331839.USD","BK4585","BK4532","IE00BJT1NW94.SGD","NVS","BK4578","LU0070302665.USD","MEDX","IE00B2B36J28.USD","IE0002141913.USD","BK4007","IE00BJJMRZ35.SGD","BK4588","PPH","IE00B4R5TH58.HKD","LU0208291251.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398915","title":"Dow Jones Top Company Headlines at 9 PM ET: Amazon Cargo Plane Overshoots Runway in Miami, Killing Five People | Carmakers ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398915","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398915?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:00","pubTimestamp":1788742800,"startTime":"0","endTime":"0","summary":"Amazon Cargo Plane Overshoots Runway in Miami, Killing Five PeopleMore than 60 Miami-Dade Fire Rescue units rushed to the scene to put out the flames and assess any injuries.----Carmakers Have a New I","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","LU2168564149.EUR","LU0965509283.SGD","LU0788109477.HKD","LU1066051811.HKD","LU2242649171.HKD","SMOG","HK0000914660.USD","LU2452424414.USD","BE","BK4592","AZYY","LU0312595415.SGD","IE0009G5SDU7.USD","LU2065170008.USD","LU2250418816.HKD","LU2505996681.GBP","RTH","LU1935042991.SGD","LU1778281490.HKD","LU1712237335.SGD","LU0390134368.USD","LU0006306889.USD","SG9999014914.USD","IE000M9KFDE8.USD","LU1852331112.SGD","SG9999004303.SGD","LU0215105999.USD","LU1629891620.HKD","VTWG","LU2592432038.USD","IE0004445239.USD","LU0057025933.USD","LU0820561909.HKD","LU2746668461.USD","SIMS","LU2430703251.USD","IE00BZ1G4Q59.USD","LU2237438978.USD","AMZY","IE0004091025.USD","IE00BSNM7G36.USD","LU2750360997.AUD","LU0310800379.SGD","LU0211331839.USD","LU0417517546.SGD","LU2764263039.SGD","LU1267930490.SGD","LU1935043023.USD","LU1815333072.USD","LU2211815571.USD","LU0345768153.USD","LU2552382132.HKD","BK4086","IE00B5TLWC47.USD","LU1064927863.SGD","LU0267386448.USD","SGXZ44715902.SGD","IE00BJJMRY28.SGD","BK4534","LU2317271919.USD","LU2065171311.SGD","SG9999017495.SGD","LU0061475181.USD","USAW.SI","LU1153585028.USD","BK4503","LU1244550577.SGD","LU0029864427.USD","LU1718418525.SGD","IE00BMPRXR70.SGD","LU2264538146.SGD","LU2089283258.USD","BK4527","LU1280957306.USD","IE0002141913.USD","IE00BQXX3C00.GBP","LU1935043536.SGD","LU0321505868.SGD","TSLY","LU0889565833.HKD","LU0321505439.SGD","LU0345770308.USD","IE00B775H168.HKD","LU0640476718.USD","LU2054465674.USD","LU0823421333.USD","ONLN","HULL","SG9999018865.SGD","BK4613","BK4516","LU2756315318.SGD","CRSH","TEST","IE000MB6IJN5.SGD","STLA","IE00B19Z3B42.SGD","BK4511","LU0072462426.USD","LU1429558221.USD","LU2063271972.USD","LU0719512351.SGD","IE00B3S45H60.SGD","LU1435385759.SGD","BK4612","IE00B1BXHZ80.USD","LU0320765489.SGD","LU0466842654.USD","LU0683600562.USD","IE00BYQQ9H92.USD","AMZN","SGXZ51526630.SGD","LU0345774391.USD","LU2552382058.USD","TSLS","BK4182","IE00BKDWB100.SGD","AMZZ","LU0130103400.USD","LU0203202063.USD","LU0742534661.SGD","LU2487616109.SGD","IE00B19Z9505.USD","LU1815336760.USD","LU0211328371.USD","LU0314104364.USD","LU0964807845.USD","LU0070217475.USD","LU0868494617.USD","LU2361045086.USD","SG9999014906.USD","LU0072461881.USD","SG9999015986.USD","LU1861559042.SGD","LU0308772762.SGD","LU2083900584.USD","LU1839511570.USD","LU0792757196.USD","LU0265550359.USD","LU0097036916.USD","LU0289739343.SGD","LU1691799644.USD","BK4550","IE00BMPRXN33.USD","LU0823434740.USD","IE00BJTD4N35.SGD","LU0107464264.USD","LU1116320901.HKD","BK4007","BK4009","LU1674673691.USD","LU0225284248.USD","LU1201861165.SGD","LU0251131958.USD","TSLT","LU0162691827.USD","LU0109391861.USD","LU0354030438.USD","LU0354030511.USD","LU2552382215.SGD","LU1868837300.USD","LU0642271901.SGD","LU0289960550.SGD","LU2108987350.USD","LU2092627202.USD","LU0256863811.USD","LU0345774631.USD","LU2860962120.EUR","TSLZ","LU2430703095.HKD","LU0127658192.USD","BK4023","LU0130102774.USD","LU2294711713.HKD","LU1868836914.USD","LU1201861249.SGD","TSII","LU2381873111.SGD","LU2111349929.HKD","AMZU","IE0009355771.USD","LU2896262040.SGD","BK4543","LU0345769631.USD","LU2458330243.SGD","IE00BK4W5M84.HKD","LU2023251221.USD","LU0048584097.USD","LU1267930573.SGD","IE00B4JS1V06.HKD","LU2168564222.USD","IE000WAW04H5.SGD","IE00B4R5TH58.HKD","TESL","LU0289941410.SGD","SG9999001424.SGD","CTEC","LU2756315664.SGD","IE00B3SWFQ91.USD","LU1066051498.USD","SG9999015978.USD","IE0005OL40V9.USD","LU0154236417.USD","LU2242650005.HKD","LU0061474705.USD","LU1917777945.USD","LU1623119135.USD","LU2420271590.USD","TTDU","IE000KEQY171.SGD","STSLAmain","LU0256863902.USD","LU0070302665.USD","LU0708995401.HKD","LU1935042488.USD","IE00BJJMRZ35.SGD","LU1934455194.USD","ADBU","BK4555","LU0557290698.USD","LU0251132253.USD","LU2236285917.USD","LU1935043452.HKD","IE0004086264.USD","IE00B19Z8X17.USD","BEZ","BK4596","LU0787776722.HKD","IE0001KFT4U8.USD","LU2750360641.GBP","TESC","LU0143551892.USD","IE000F7OJYX1.SGD","LU0348723411.USD","LU1791710400.SGD","BK4528","HK0000914686.HKD","IE00BMPRXQ63.HKD","LU0238689110.USD","AMZD","HYDR","LU2168564065.EUR","TSLP","LU0048573561.USD","LU0096362180.USD","IE000SO60NU8.SGD","LU0980610538.SGD","LU0965509101.SGD","AMZP","LU0234572021.USD","SGXZ81514606.USD","LU1674673428.USD","LU2506951792.HKD","LU0472753341.HKD","LU0306806265.USD","LU0316494557.USD","LU1880398554.USD","LU2471134952.CNY","TSLI","LU2357305700.SGD","LU1366192091.USD","IE00BJJMRX11.SGD","LU2249611893.SGD","LU1037948897.HKD","LU2092937148.SGD","BK4559","LU0096364046.USD","LU0198837287.USD","LU0456855351.SGD","LU0061474960.USD","IE00BJT1NW94.SGD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU2077746001.SGD","IE00B775SV38.USD","CLIX","MEDX","IE00BQXX3F31.USD","LU0949170426.SGD","LU1267930730.SGD","LU0170899867.USD","IE00BKVL7J92.USD","LU0985481810.HKD","BK4561","BK4554","LU2265009873.SGD","SGXZ31699556.SGD","LU0965509010.AUD","LU0077335932.USD","LU0082616367.USD","07366","LU2087625088.SGD","LU0323591593.USD","IE000YTNTUN2.SGD","LU1244550494.USD","LU0823414551.USD","NVS","LU0511384066.AUD","LU2361044865.SGD","SGXZ80539844.SGD","LU1066053197.SGD","LU1642822529.SGD","IE00B1XK9C88.USD","LU2764263203.CNY","LU2168564495.EUR","IE00BFSS8Q28.SGD","SG9999015952.SGD","LU0943347566.SGD","LU0786609619.USD","LU0648001328.SGD","LU0234570918.USD","EGGY","SG9999000418.SGD","F","LU1791710582.SGD","LU0823421416.USD","LU2362540622.SGD","LU2462591350.SGD","LU0265550946.USD","LU1119994496.HKD","LU2023250843.SGD","SG9999018857.SGD","LU0158827948.USD","AMZO","BEX","LU0175139822.USD","BEG","IE000BZT7R73.USD","LU1244550221.USD","BK4598","HK0000304797.USD","LU0689472784.USD","ILDR","ICLN","LU2461242641.AUD","AMZG","TSLL","LU1046421795.USD","LU0174119429.USD","LU2746668974.SGD","LU1861127337.USD","LU1868836757.USD","LU2211817866.USD","LU0053666078.USD","LU1861558580.USD","LU1868837136.USD","LU1934455863.HKD","LU1127390331.HKD","LU2213496289.HKD","LU0069063385.USD","BK4158","LU2028103732.USD","LU1861220033.SGD","LU1633808545.USD","LU2247934214.USD","BK4220","LU2023250504.SGD","LU1069344957.HKD","LU0210528500.USD","LU2106854487.HKD","LU2357125470.USD","TSLA","BK4533","LU0289961442.SGD","LU0345769128.USD","BK4548","LU2095319765.USD","BK4524","LU2471134879.HKD","LU2097829019.USD","OGIG","LU2360032135.SGD","SAMZNmain","LU0648000940.SGD","LU2999663052.SGD","LU1035775433.USD","IE000ITXATA3.USD","LU0784385170.HKD","LU2602419157.SGD","LU0210536198.USD","LIT","LU1084165304.USD","BK4581","LU2403377893.USD","LU1074936037.SGD","LU0820561818.USD","LU1720051108.HKD","BK4567","IE00BFSS7M15.SGD","LU2125154778.USD","LU0276348264.USD","LU0708994859.HKD","IE000W1ABFV2.USD","LU0210533765.USD","TSL","LU0871640123.AUD","FRDD","LU0823414478.USD","LU0157215616.USD","LU0985320562.USD","AMZW","LU1988902786.USD","BK4579","LU1323610961.USD","HK0000532082.HKD","LU0251142724.SGD","LU0724617625.USD","XHB","07766","TLA","LU0444971666.USD","IE00B19Z3581.USD","LU0208291251.USD","IE0004445015.USD","LU0784384876.USD","ADBE","LU1496350502.SGD","LU2637965513.SGD","IE0002270589.USD","LU2430703178.SGD","LU2456880835.USD","SGXZ99366536.SGD","LU2290526834.HKD","LU1861215975.USD","BK4538","IE00BJLML261.HKD","LU1064131342.USD","LU2462591277.SGD","BK4535","LU2462157665.USD","LU2210150020.SGD","LU0494093205.USD","SG9999001077.SGD","LU1814569148.SGD","LU0476273544.USD","IE00B2B36J28.USD","LU0138981039.USD","LU2360107168.USD","ADBG","LU0203201768.USD","LU0302445910.USD","LU1037948541.HKD","LU2065171402.SGD","LU0080751232.USD","LU1235294995.USD","SG9999002224.SGD","BK4551","LU2275660780.HKD","LU2065169927.USD","LU0957791311.USD","TSLR","LU0672654240.SGD","LU1496350171.SGD","LU2463028550.USD","LU0225771236.USD","BK4532","LU0820562030.AUD","LU0882574139.USD","IE00BFTCPJ56.SGD","LU1935042215.USD","BK4566","LU1316542783.SGD","BEC","BK4588","LU2471134523.USD","LU2087621335.USD","LU0306807586.USD","LU2023250330.USD","LU0345768740.USD","IE0009356076.USD","TSLW","LU1979441026.SGD","IE00BQXX3D17.EUR","LU2089284900.SGD","LU1145028129.USD","IE00BK4W5L77.USD","LU0320765059.SGD","IE0000B7K699.USD","LU0345770993.USD","LU0823434583.USD","LU2471134796.USD","LU0310799852.SGD","LU1066051225.USD","ELOL","LU1804176565.USD","IE0009354923.USD","VCLN","LU0011850046.USD","LU2362541273.HKD","LU0942090050.USD","SGXZ23171101.USD","SG9999014880.SGD","LU0353189763.USD","LU2168563687.JPY","BK4541","LU0784385840.USD","LU1880398471.USD","LU2362541513.USD","LU2543165471.USD","LU1366333091.USD","LU2764262908.HKD","IE00B7KXQ091.USD","LU1301847155.USD","BK4122","LU0109392836.USD","LU0861579265.USD","LU2361044949.HKD","LU2125154935.USD","TAP","IE00BWXC8680.SGD","HK0000304805.HKD","LU1261432733.SGD","LU0079474960.USD","LU0353189680.USD","LU1551013342.USD","SG9999015945.SGD","AMAA","LU1116320737.USD","LU1914381329.SGD","FRNW","LU0158827781.USD","LU1934455277.USD","LU0133085943.USD","LU1823568750.SGD","IE00BJTD4V19.USD","LU0106261372.USD","IE00B5949003.HKD","TSLO","IDRV","LU2505996509.AUD","BK4578","LU0342679015.USD","ZAP","LU0444973449.USD","LU0128525929.USD","IE0034235303.USD","LU2237957811.SGD","SG9999014898.SGD","LU0784383803.USD","LU2720916845.USD","GB00BDT5M118.USD","LU0149725797.USD","LU0889566641.SGD","09366","TSDD","LU2210149790.SGD","09766","PPH","LU0081259029.USD","LU0528227936.USD","LU1548497426.USD","LU0056508442.USD","LU0823411888.USD","LU2458330169.SGD","BK4604","LU1803068979.SGD","CNRG","LU0965508806.USD","LU1232071149.USD","BK4099","IE00B4YYXB79.USD","BK4585","LU1974910355.USD","LU1989764664.SGD","LU1868836591.USD","UPGR","LU0868494708.USD","LU2360106780.USD","IE00BKPKM429.USD","LU1989764748.USD","LU2326559502.SGD","BLDR","IE0003U64NQ7.SGD","LU0211327993.USD","LU1551013425.SGD","FDRV","LU2271345857.HKD","WATS","LU2237957902.USD","TSYY","TTD","IE00B19Z8W00.USD","LU2417539215.USD","LU2954938101.SGD","SG9999002232.USD","LU1267930813.SGD","WANT","IE00BN29S564.USD","FRDU","LU0957808578.USD","BK4507","BK4574","IBAT","IE00BFXG0V08.USD","TSLG","LU1883839398.USD","TSLQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398326","title":"Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398326","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398326?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:23","pubTimestamp":1788740626,"startTime":"0","endTime":"0","summary":"The latest update is out from LBT Innovations Limited ( ($AU:CC5) ). Clever Culture Systems Ltd, an Adelaide-based specialist in AI microbiology au...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/clever-culture-systems-wins-expanded-novo-nordisk-order-as-apas-nears-global-validation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/clever-culture-systems-wins-expanded-novo-nordisk-order-as-apas-nears-global-validation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","NVOH","OZEM","BK4585","NVOX","NVO","THNR","BK7007","IE00BZ1G4Q59.USD","BK4532","BK4007","LU0154236417.USD","PPH","IE00BKVL7J92.USD","LU1093756325.SGD","CC5.AU","NVOC","BK4599","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365115","title":"A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665365115?lang=en_us&edition=fundamental","pubTime":"2026-09-06 02:01","pubTimestamp":1788631260,"startTime":"0","endTime":"0","summary":"In a consequential week for Novartis, the Swiss drug maker released results for two of three trials that Wall Street has watched for in the second half of the year.Novartis saw U.S.-listed shares soar","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2456880835.USD","TBXU","BK4504","LU0868494617.USD","LU1057294990.SGD","LU2112291526.USD","IBBQ","LU0980610538.SGD","TFNS","LU2462157665.USD","LU2236285917.USD","LU0889565916.HKD","AMGN","PJP","BK4533","BK4599","LU2125154935.USD","SG9999001440.SGD","LU0320765489.SGD","LU2242652126.USD","BK4559","BK4566","IBB","LU0211331839.USD","BIB","LU0052756011.USD","LU1244550221.USD","BK4139","LU1162221912.USD","NVS","PBE","LU0314106906.USD","FTXO","LU1061106388.HKD","LU2360032135.SGD","IYF","LU1074936037.SGD","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4007","LU0128525689.USD","PPH","LU0106831901.USD","LU1983299246.USD","IE00BSNM7G36.USD","MEDX","BBH","LU2242646821.SGD","LU0130102774.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665636863","title":"Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.","url":"https://stock-news.laohu8.com/highlight/detail?id=2665636863","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665636863?lang=en_us&edition=fundamental","pubTime":"2026-09-05 20:30","pubTimestamp":1788611400,"startTime":"0","endTime":"0","summary":"Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgeryBoomers are the suddenly the fastest-growing customers for cosmetic surgery.Baby boomers are the wealthiest ge","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IE00B19Z3581.USD","ESTA","LU1244550221.USD","LU2237443622.USD","LU1670627923.USD","IE000F7OJYX1.SGD","LU1023059063.AUD","SG9999015978.USD","LU0289739343.SGD","LU1057294990.SGD","XLV","LU1037948897.HKD","IE00BVYPNW00.USD","RXL","IE000WAW04H5.SGD","LU0395794307.EUR","IE00BN8TJ469.HKD","LU0965509283.SGD","LU0823416689.USD","LU1929549753.HKD","IE00B42XCP33.USD","LU0553294199.USD","LU0942090050.USD","IE00BDGV0183.EUR","LU0211327993.USD","LU1732800096.USD","IXJ","LU1670628061.USD","MEDX","LU2112291526.USD","LU0417517546.SGD","SG9999015952.SGD","LU2357627491.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0203345920.USD","LU0882574055.USD","LU1923622614.USD","AGNG","SG9999015945.SGD","LU1267930490.SGD","GALDY","LU0211328371.USD","LU0122379950.USD","FTXH","IE00B19Z3B42.SGD","LU0128525929.USD","LU2087621335.USD","LU2089984988.USD","LU2347655156.SGD","LU2237443465.HKD","PPH","LU1983299246.USD","SG9999001440.SGD","IE00BVYPNV92.GBP","LU1551013425.SGD","IE00BLSP4239.USD","SG9999015986.USD","LU0689626769.HKD","IE00BBT3K403.USD","LU0965509101.SGD","LU0859254822.USD","IE000BZT7R73.USD","LU0861579265.USD","LU0256863811.USD","LU1496350502.SGD","LU0511384066.AUD","BK4139","LU1093756168.USD","LU1718418525.SGD","LU2433249047.HKD","SG9999003800.SGD","IYH","IE0009355771.USD","LU2023251221.USD","IE0000B7K699.USD","LU1267930573.SGD","LU0868494708.USD","IE00BLSP4452.SGD","LU0158827948.USD","LU0098860793.USD","LU2468319806.SGD","LU0432979614.USD","VHT","LU1585245621.USD","LU0203347892.USD","LU1934455277.USD","TRUH","BK4559","BK4534","LU0310800379.SGD","GLAM","LU1236620834.HKD","LU1839511570.USD","LU2324357040.USD","LU0069063385.USD","LU2133065610.SGD","LU0965509010.AUD","IE00BGHQF631.EUR","LU1003077747.HKD","LU0289961442.SGD","BK4566","LU1989772840.SGD","LU0965508806.USD","LU1989771016.USD","LU1934455863.HKD","LU0912757837.SGD","LU0795875169.SGD","LU0820561909.HKD","LU2237443382.USD","LU2129689605.HKD","BK4588","LU0057025933.USD","LU0234570918.USD","LU0320765646.SGD","IE00BJJMRZ35.SGD","LU0820561818.USD","LU1732799900.SGD","LU2237443978.SGD","LU1291159041.SGD","LU0234572021.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU0310799852.SGD","FHLC","IE00B3PB1722.GBP","LU0726765562.USD","LU1244550577.SGD","LU2125909593.SGD","BK4585","LU0545039389.USD","LU0198837287.USD","BK4581","LU0170899867.USD","ABBV","LU0029864427.USD","LU0114720955.EUR","PJP","LU1430594728.SGD","LU2237443549.SGD","LU0868494617.USD","LU0124676726.USD","BK4007","LU1496350171.SGD","LU1551013342.USD","LU0985320562.USD","IE00BSNM7G36.USD","LU1236620750.USD","IE000SO60NU8.SGD","LU0708994859.HKD","BK4198","BK4533","LU0289739699.SGD","LU0456855351.SGD","LU0738911758.USD","LU0795875086.SGD","LU2129689514.USD","LU1093756325.SGD","LU1037948541.HKD","LU0472753341.HKD","IE0004445239.USD","IE000MB6IJN5.SGD","SG9999011175.SGD","LU1074936037.SGD","BK4550","LU2089284900.SGD","LU2129689431.USD","LU1244550494.USD","LU0943347566.SGD","IE00BFTCPJ56.SGD","LU0661504455.SGD","LU2125909247.SGD","LU0058720904.USD","LU2089283258.USD","LU2237443895.HKD","LU1162221912.USD","LU0256863902.USD","LU1934455194.USD","LU1989772923.USD","LU0689472784.USD","IE0002270589.USD","LU2347655073.USD","LU0949170772.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665524173","title":"Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2665524173","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665524173?lang=en_us&edition=fundamental","pubTime":"2026-09-05 07:55","pubTimestamp":1788566100,"startTime":"0","endTime":"0","summary":"A highly anticipated cholesterol drug from Novartis failed to reduce the risk of severe cardiovascular outcomes in a Phase 3 study, dealing a blow to the company and others exploring a new approach to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE0009355771.USD","NVS","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","MEDX","IE0002141913.USD","PPH","LU0211331839.USD","BK4588","BK4585","LU0070302665.USD","BK4007","IE00BJJMRZ35.SGD","LU0208291251.USD","IE00B4R5TH58.HKD","BK4532","BK4578","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665352693","title":"Stocks to Watch: Ionis Pharmaceuticals, Novartis, Corvex","url":"https://stock-news.laohu8.com/highlight/detail?id=2665352693","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665352693?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:58","pubTimestamp":1788562680,"startTime":"0","endTime":"0","summary":"A heart disease drug made by Ionis Pharmaceuticals and Novartis didn't meet its primary endpoint in a Phase 3 trial. Ionis shares slid 9.5% to $52.60 in after-hours trading on Friday, while Novartis shares were off 4.4% at $153.04.Corvex said it had a loss of $26.3 million in the first half of the year. The stock fell 7.5% to $13.63 after the bell.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0211331839.USD","NVS","IONS","PPH","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0070302665.USD","IE00BJT1NW94.SGD","MEDX","IE00BFTCPJ56.SGD","BK4578","BK4007","LU0320765489.SGD","BK4588","BK4585","BK4532","BK4170","MOVE","BK4139","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354352","title":"Novartis Pelacarsen Fails Phase III Cardiovascular Outcomes Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354352","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354352?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:36","pubTimestamp":1788561414,"startTime":"0","endTime":"0","summary":"Novartis AG (NVS) said Friday its Phase III Lp(a)HORIZON trial of pelacarsen did not meet its primary endpoint of reducing the risk of cardiovascular events compared with placebo.The primary endpoint ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFTCPJ56.SGD","LU0211331839.USD","PPH","MEDX","BK4585","BK4578","BK4588","BK4082","LU0070302665.USD","NVS","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4532","IE0002141913.USD","BK4007","LU0320765489.SGD","LU0208291251.USD","IE00B2B36J28.USD","CSII","IE00BJT1NW94.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":10,"totalSize":241,"code":"91000000","status":"200"}]}}